Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice

Diabetes Research and Clinical Practice

Volumn 34, Issue 1, 1996, Pages 7-11

  Kaino, Yukikazu ^a   Hirai, Hiroki ^a   Ito, Takuo ^a   Kida, Kaichi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

insulin like growth factor I; insulitis; non obese diabetic (NOD) mouse; prophylaxis; type 1 (insulin dependent) diabetes mellitus

Indexed keywords

SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN;

AGING; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; INCIDENCE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD;

EID: 0030248933     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(96)01326-5     Document Type: Article

References (10)

1. [1] Eisenbarth, G.S. (1986) Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314, 1360-1368.
2. [2] Gotfredsen, C.F., Buschard, K. and Frandsen, E.K. (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28, 933-935.
3. [3] Atkinson, M.A., MacLaren, N.K. and Luchetta, R. (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39, 933-937.
4. [4] Vlahos, W.D., Seemayer, T.A. and Yale, J.-F. (1991) Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism 40, 825-829.
5. [5] Zhang, J.Z., Davidson, L., Eisenbarth, G. and Weiner, H.L. (1991) Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88, 10252-10256.
6. [6] Shah, S.C., Malone, J.I. and Simpson, N.E. (1989) A randomized trial of intensive insulin therapy in newly-diagnosed insulin-dependent diabetes mellitus. N. Engl. J. Med. 320, 550-554.
7. [7] Keller, R.J., Eisenbarth, G.S. and Jackson, R.A. (1993) Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341, 927-928.
8. [8] Kolaczynski, J.W. and Caro, J.F. (1994) Insulin-growth factor-I therapy in diabetes: physiologic basis, clinical benefits, and risks. Ann. Intern. Med. 120, 47-57.
9. [9] Froesch, E.R. and Hussain, M. (1994) Recombinant human insulin-like growth factor-I: a therapeutic challenge for diabetes mellitus. Diabetologia 37 (Suppl. 2), S179-S185.
10. [10] Muir, A., Peck, A., Clare-Salzler, M. et al. (1995) Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest. 95, 628-634.